한글목차

심낭염 시장 규모는 최근 몇 년간 크게 성장했습니다. 2025년 24억 9,000만 달러에서 2026년에는 26억 9,000만 달러에 이르고, CAGR 7.9%의 성장이 전망되고 있습니다. 지난 몇 년간의 성장 요인으로는 심낭염에 대한 낮은 인지도, 기존 진단법에 대한 의존도, 낮은 첨단 영상진단 기술 보급률, 전문 심장 의료에 대한 접근성 제한, 병원 중심의 치료 중심 등을 꼽을 수 있습니다.

향후 몇 년간 심낭염 시장 규모는 견고성장이 전망됩니다. 2030년에는 36억 4,000만 달러에 이르고, CAGR은 7.9%를 나타낼 전망입니다. 예측 기간의 성장 요인으로는 심혈관 질환의 유병률 증가, 디지털 진단 기술의 보급 확대, 외래수술센터(ASC)의 확대, 정밀의료에 대한 투자 증가, 심장 치료에 대한 AI 통합 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 개인화된 심낭염 치료 접근법, 최소침습 수술 기술, 조기 진단 기술 혁신, 웨어러블 심장 모니터링의 통합, 외래 심장 진료 서비스 확대 등이 있습니다.

심혈관 질환의 유병률 증가는 향후 심낭염 시장 확대를 견인할 것으로 예측됩니다. 심혈관 질환은 심장과 혈관에 영향을 미치는 병태를 말하며, 동맥 내 지방 침착의 축적과 혈액 응고 위험 증가와 관련이 있습니다. 심낭염을 방치하면 각종 심혈관 질환을 유발할 수 있으며, 심할 경우 사망에 이를 수도 있습니다. 따라서 심혈관 질환 증가율이 심낭염 시장의 성장을 가속하고 있습니다. 예를 들어, 2024년 1월 미국 비영리단체인 미국심장협회가 발표한 자료에 따르면, 2024년 심혈관 질환으로 인한 연령 조정 사망률은 2024년 10만 명당 233.3명으로 2023년 224.4명에서 4.0% 증가했다고 합니다. 따라서 심혈관 질환의 유병률 증가는 심낭염 치료 기기 시장의 성장을 가속하고 있습니다.

심낭염 시장의 성장은 헬스케어 지출 증가에 의해 주도될 것으로 예측됩니다. 의료비 지출은 특정 지역, 국가 또는 의료 시스템 내에서 다양한 의료 서비스 및 활동에 할당되는 총 자금을 의미합니다. 의료비 지출 증가는 조사, 진단, 치료, 환자 교육 등 심낭염의 종합적인 관리를 지원하는 환경을 조성하여 궁극적으로 이 질환을 앓고 있는 개인에게 혜택을 줄 수 있습니다. 예를 들어, 2023년 5월 영국 정부 기관인 국가통계청이 발표한 바에 따르면, 영국의 의료비 지출은 2022년부터 2023년까지 5.6% 증가하여 2022년의 0.9% 증가에서 크게 증가하였습니다. 영국의 의료비 지출은 2023년 약 3,176억 3,000만 달러(2,920억 파운드)에 달할 것으로 예측됩니다. 그 결과, 의료비 지출 증가는 심낭염 시장의 성장을 가속할 것으로 예측됩니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Pericarditis is the inflammation and irritation of the pericardium, the thin, saclike tissue surrounding the heart. The most common symptom is chest pain, which occurs when the layers of the sac rub against the heart and become inflamed.

The main types of pericarditis include acute, chronic, and recurrent pericarditis. Acute pericarditis is a painful inflammation that develops suddenly in the pericardium surrounding the heart. Pericarditis can be diagnosed and treated using various methods, including electrocardiogram (ECG), echocardiogram, computerized tomography (CT), x-ray, medication, and, in some cases, surgical treatment. The treatment of pericarditis is used in a variety of settings, such as hospitals and clinics, medical institutions, ambulatory surgical centers, and research organizations.

Tariffs have influenced the pericarditis market by affecting the import and cost of advanced medical devices and diagnostic equipment used for treatment and monitoring. Segments such as echocardiogram, ct, and surgical treatment are most impacted, particularly in regions dependent on imports like Asia-Pacific and Europe. The tariffs have increased production and procurement costs, potentially slowing adoption in hospitals and clinics. However, this has also encouraged local manufacturing and innovation in cost-effective diagnostic solutions, creating some positive opportunities for domestic players.

The pericarditis market research report is one of a series of new reports from The Business Research Company that provides pericarditis market statistics, including pericarditis industry global market size, regional shares, competitors with a pericarditis market share, detailed pericarditis market segments, market trends and opportunities, and any further data you may need to thrive in the pericarditis industry. This pericarditis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pericarditis market size has grown strongly in recent years. It will grow from $2.49 billion in 2025 to $2.69 billion in 2026 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to limited awareness of pericarditis, reliance on traditional diagnostics, low adoption of advanced imaging, restricted access to specialized cardiac care, predominance of hospital-based treatment.

The pericarditis market size is expected to see strong growth in the next few years. It will grow to $3.64 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to growing prevalence of cardiovascular disorders, increasing adoption of digital diagnostics, expansion of outpatient surgical centers, rising investment in precision medicine, integration of AI in cardiac care. Major trends in the forecast period include personalized pericarditis treatment approaches, minimally invasive surgical techniques, early diagnostic innovations, integration of wearable cardiac monitoring, expansion of outpatient cardiac care services.

The growing prevalence of cardiovascular diseases is expected to drive the expansion of the pericarditis market in the future. Cardiovascular diseases refer to conditions that affect the heart or blood vessels, often linked to the buildup of fatty deposits inside the arteries and an increased risk of blood clotting. If left untreated, pericarditis can lead to various cardiovascular diseases or even death in extreme cases. As such, the rising rates of cardiovascular diseases are fueling the growth of the pericarditis market. For example, in January 2024, the American Heart Association, a U.S.-based non-profit organization, reported that the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000 in 2024, a 4.0% rise from 224.4 per 100,000 in 2023. Therefore, the increasing prevalence of cardiovascular diseases is driving the growth of the pericarditis devices market.

The growth of the pericarditis market is expected to be driven by increased healthcare spending. Healthcare spending refers to the total financial resources allocated to various healthcare services and activities within a specific region, country, or healthcare system. Higher healthcare spending fosters an environment that supports the comprehensive management of pericarditis, including research, diagnosis, treatment, and patient education, ultimately benefiting individuals with this condition. For instance, in May 2023, the Office for National Statistics, a UK-based government department, reported that healthcare spending in the UK increased by 5.6% between 2022 and 2023, compared to a growth of 0.9% in 2022. The UK's healthcare expenditure reached approximately $317.63 billion (£292 billion) in 2023. As a result, increased healthcare spending is expected to drive the growth of the pericarditis market.

Major companies operating in the pediatric market are focused on developing next-generation monoclonal antibodies to improve treatment options, enhance therapeutic outcomes, and minimize side effects for children with various medical conditions. These next-generation monoclonal antibodies are engineered to provide better efficacy, specificity, and safety when targeting diseases. For example, in January 2024, Coherus BioSciences, a U.S.-based biotechnology company, launched LOQTORZITM. LOQTORZI is used in combination with cisplatin and gemcitabine for the first-line treatment of adults with metastatic or recurrent locally advanced nasopharyngeal carcinoma (NPC). It can also be used as a monotherapy for patients with recurrent, unresectable, or metastatic NPC who have progressed after platinum-containing chemotherapy, regardless of PD-L1 status.

Major companies operating in the pericarditis market are Pfizer Inc., AstraZeneca plc, Merck & Co. Inc., Novartis International AG, Johnson & Johnson Services Inc., Takeda Pharmaceutical Co. Ltd., Zydus Cadila Healthcare Ltd., Sun Pharmaceutical Ltd., Kiniksa Pharmaceuticals Ltd., Regeneron Pharmaceuticals Inc., Amgen Inc., Merck KGaA, Hikma Pharmaceuticals plc, AbbVie Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline plc, Sanofi S.A., Teva Pharmaceutical Industries Ltd., Bayer AG, Roche Holding AG, Daiichi Sankyo Company Limited, Astellas Pharma Inc.

North America was the largest region in the pericarditis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the pericarditis market report during the forecast period. The regions covered in the pericarditis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pericarditis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pericarditis market consists of sales of bacterial pericarditis, viral pericarditis, constrictive pericarditis, and subacute pericarditis. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The pericarditis market is segmented into bacterial pericarditis, viral pericarditis, constrictive pericarditis and other pericarditis.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pericarditis Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses pericarditis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pericarditis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pericarditis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Acute Pericarditis; Chronic Pericarditis; Recurrent Pericarditis
• 2) By Diagnosis And Treatment: Electrocardiogram (ECG); Echocardiogram; Computerized Tomography (Ct); X-Ray; Medication; Surgical Treatment
• 3) By Application: Hospitals And Clinics; Medical Institutes; Ambulatory Surgical Centers; Research Organizations
• Subsegments:
• 1) By Acute Pericarditis: Viral Pericarditis; Bacterial Pericarditis; Idiopathic Pericarditis
• 2) By Chronic Pericarditis: Constrictive Pericarditis; Non-constrictive Chronic Pericarditis
• 3) By Recurrent Pericarditis: Post-Acute Pericarditis Recurrences; Secondary Recurrent Pericarditis
• Companies Mentioned: Pfizer Inc.; AstraZeneca plc; Merck & Co. Inc.; Novartis International AG; Johnson & Johnson Services Inc.; Takeda Pharmaceutical Co. Ltd.; Zydus Cadila Healthcare Ltd.; Sun Pharmaceutical Ltd.; Kiniksa Pharmaceuticals Ltd.; Regeneron Pharmaceuticals Inc.; Amgen Inc.; Merck KGaA; Hikma Pharmaceuticals plc; AbbVie Inc.; Bristol-Myers Squibb Company; Eli Lilly and Company; GlaxoSmithKline plc; Sanofi S.A.; Teva Pharmaceutical Industries Ltd.; Bayer AG; Roche Holding AG; Daiichi Sankyo Company Limited; Astellas Pharma Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Pericarditis Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Pericarditis Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Pericarditis Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Pericarditis Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Artificial Intelligence & Autonomous Intelligence
  • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.1.5 Industry 4.0 & Intelligent Manufacturing
• 4.2. Major Trends
  • 4.2.1 Personalized Pericarditis Treatment Approaches
  • 4.2.2 Minimally Invasive Surgical Techniques
  • 4.2.3 Early Diagnostic Innovations
  • 4.2.4 Integration Of Wearable Cardiac Monitoring
  • 4.2.5 Expansion Of Outpatient Cardiac Care Services

5. Pericarditis Market Analysis Of End Use Industries

• 5.1 Hospitals And Clinics
• 5.2 Medical Institutes
• 5.3 Ambulatory Surgical Centers
• 5.4 Research Organizations
• 5.5 Cardiology Specialty Centers

6. Pericarditis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Pericarditis Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Pericarditis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Pericarditis Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Pericarditis Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Pericarditis Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Pericarditis Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Pericarditis Market Segmentation

• 9.1. Global Pericarditis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Acute Pericarditis, Chronic Pericarditis, Recurrent Pericarditis
• 9.2. Global Pericarditis Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Electrocardiogram (ECG), Echocardiogram, Computerized Tomography (CT), X-Ray, Medication, Surgical Treatment
• 9.3. Global Pericarditis Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals And Clinics, Medical Institutes, Ambulatory Surgical Centers, Research Organizations
• 9.4. Global Pericarditis Market, Sub-Segmentation Of Acute Pericarditis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Viral Pericarditis, Bacterial Pericarditis, Idiopathic Pericarditis
• 9.5. Global Pericarditis Market, Sub-Segmentation Of Chronic Pericarditis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Constrictive Pericarditis, Non-constrictive Chronic Pericarditis
• 9.6. Global Pericarditis Market, Sub-Segmentation Of Recurrent Pericarditis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Post-Acute Pericarditis Recurrences, Secondary Recurrent Pericarditis

10. Pericarditis Market Regional And Country Analysis

• 10.1. Global Pericarditis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Pericarditis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Pericarditis Market

• 11.1. Asia-Pacific Pericarditis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Pericarditis Market, Segmentation By Type, Segmentation By Diagnosis And Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Pericarditis Market

• 12.1. China Pericarditis Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Pericarditis Market, Segmentation By Type, Segmentation By Diagnosis And Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Pericarditis Market

• 13.1. India Pericarditis Market, Segmentation By Type, Segmentation By Diagnosis And Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Pericarditis Market

• 14.1. Japan Pericarditis Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Pericarditis Market, Segmentation By Type, Segmentation By Diagnosis And Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Pericarditis Market

• 15.1. Australia Pericarditis Market, Segmentation By Type, Segmentation By Diagnosis And Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Pericarditis Market

• 16.1. Indonesia Pericarditis Market, Segmentation By Type, Segmentation By Diagnosis And Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Pericarditis Market

• 17.1. South Korea Pericarditis Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Pericarditis Market, Segmentation By Type, Segmentation By Diagnosis And Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Pericarditis Market

• 18.1. Taiwan Pericarditis Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Pericarditis Market, Segmentation By Type, Segmentation By Diagnosis And Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Pericarditis Market

• 19.1. South East Asia Pericarditis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Pericarditis Market, Segmentation By Type, Segmentation By Diagnosis And Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Pericarditis Market

• 20.1. Western Europe Pericarditis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Pericarditis Market, Segmentation By Type, Segmentation By Diagnosis And Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Pericarditis Market

• 21.1. UK Pericarditis Market, Segmentation By Type, Segmentation By Diagnosis And Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Pericarditis Market

• 22.1. Germany Pericarditis Market, Segmentation By Type, Segmentation By Diagnosis And Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Pericarditis Market

• 23.1. France Pericarditis Market, Segmentation By Type, Segmentation By Diagnosis And Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Pericarditis Market

• 24.1. Italy Pericarditis Market, Segmentation By Type, Segmentation By Diagnosis And Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Pericarditis Market

• 25.1. Spain Pericarditis Market, Segmentation By Type, Segmentation By Diagnosis And Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Pericarditis Market

• 26.1. Eastern Europe Pericarditis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Pericarditis Market, Segmentation By Type, Segmentation By Diagnosis And Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Pericarditis Market

• 27.1. Russia Pericarditis Market, Segmentation By Type, Segmentation By Diagnosis And Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Pericarditis Market

• 28.1. North America Pericarditis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Pericarditis Market, Segmentation By Type, Segmentation By Diagnosis And Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Pericarditis Market

• 29.1. USA Pericarditis Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Pericarditis Market, Segmentation By Type, Segmentation By Diagnosis And Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Pericarditis Market

• 30.1. Canada Pericarditis Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Pericarditis Market, Segmentation By Type, Segmentation By Diagnosis And Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Pericarditis Market

• 31.1. South America Pericarditis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Pericarditis Market, Segmentation By Type, Segmentation By Diagnosis And Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Pericarditis Market

• 32.1. Brazil Pericarditis Market, Segmentation By Type, Segmentation By Diagnosis And Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Pericarditis Market

• 33.1. Middle East Pericarditis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Pericarditis Market, Segmentation By Type, Segmentation By Diagnosis And Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Pericarditis Market

• 34.1. Africa Pericarditis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Pericarditis Market, Segmentation By Type, Segmentation By Diagnosis And Treatment, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Pericarditis Market Regulatory and Investment Landscape

36. Pericarditis Market Competitive Landscape And Company Profiles

• 36.1. Pericarditis Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Pericarditis Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Pericarditis Market Company Profiles
  • 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Pericarditis Market Other Major And Innovative Companies

• Takeda Pharmaceutical Co. Ltd., Zydus Cadila Healthcare Ltd., Sun Pharmaceutical Ltd., Kiniksa Pharmaceuticals Ltd., Regeneron Pharmaceuticals Inc., Amgen Inc., Merck KGaA, Hikma Pharmaceuticals plc, AbbVie Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline plc, Sanofi S.A., Teva Pharmaceutical Industries Ltd., Bayer AG

38. Global Pericarditis Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Pericarditis Market

40. Pericarditis Market High Potential Countries, Segments and Strategies

• 40.1 Pericarditis Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Pericarditis Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Pericarditis Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer